Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Hair follicles may soon be used more for targeted and systemic drug delivery.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Micrografts promote hair growth in androgenetic alopecia treatment.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Caffeine improves hair growth, thickness, and reduces shedding.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Too much epidermal growth factor can cause hair loss.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Topical bimatoprost 0.01% improves eyebrow density and diameter, especially at the tail.